Amgen ends marketing agreement with GSK for osteoporosis drug
(Reuters) - Amgen Inc said it would end an agreement with GlaxoSmithKline Plc for the marketing of its osteoporosis drug in some regions outside the U...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Mjp2hv0MTxw/story01.htm
No comments:
Post a Comment